Check out which companies are making headlines in pre-market trading. Robinhood – Shares of the brokerage firm jumped more than 6% after unveiling the Robinhood Gold Card, a credit card through which cash can be deposited into a brokerage account. Concentrix – Shares fell nearly 4% on disappointing fiscal second-quarter earnings guidance. The customer experience technology company also reiterated its full-year outlook for 2024. Shares of GameStop fell more than 17% after the video game retailer reported a significant drop in revenue in the fourth quarter compared to the same period a year earlier. The company added that it has also reduced its workforce by an unspecified number across the quartet to cut costs. Moderna – Shares rose 3.5% after the drug company said it has advanced three vaccines into final-stage trials. Separately, Blackstone Lifesciences said it would provide up to $750 million in funding for Moderna's influenza program. nCino – The cloud software company gained nearly 12% after the company reported a 13% revenue increase in the first quarter compared to the previous year. The company's fourth-quarter profits also exceeded analysts' expectations. Krispy Kreme – Shares rose more than 2%, adding to a 39% rise from the previous session. The company announced Tuesday that it will expand its partnership with McDonald's to sell donuts at the fast-food chain's restaurants, with nationwide availability estimated by 2026. Viking Therapeutics — Shares rose nearly 3%. In the previous session, the stock rose more than 15% after promising trial results for weight loss pills. Deutsche Bank – Shares rose 3% after an upgrade to overweight from Morgan Stanley. The company said the German bank may have more room to run despite strong gains in 2024. Shares of Trump Media and Technology Group — former President Donald Trump's social media company — rose nearly 14% after debuting as a publicly traded company earlier. from today. Merck — Shares posted a nearly 5% gain after the Food and Drug Administration approved Merck's life-threatening lung condition treatment, Winrevair, for use among adults with pulmonary arterial hypertension. Carnival – Shares added 2% ahead of the cruise operator's first-quarter earnings report, due before the bell. Analysts surveyed by FactSet expect a loss of 17 cents per share and quarterly revenue of $5.33 billion. Carnival stock rose 130% in 2023 as the industry recovered from Covid, but is down 8% so far this year, lagging its peers. – CNBC's Michelle Fox, Sarah Main and Jesse Pound contributed reporting.
